1 Introduction Obesity, diagnosed as a body mass index (BMI) 30 kg/m 2 , is a progressive, chronic disease that has grown to pandemic prevalence over the past decades ( Figure 1 ) ( Figure 1 While traditionally recognized primarily as a disease of the elderly, T2D is currently one of the most frequently diagnosed preventable chronic diseases in middle age, as well as children and adolescents ( Lifestyle modifications, such as balanced nutrition, calorie restriction and physical exercise, remain the cornerstone of any weight loss intervention
Retatrutide is currently an investigational medication and has not received FDA approval for routine clinical use
Gastrointestinal Tolerance: Your digestive system needs time to adjust
A case report of systemic allergic reaction to the dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist tirzepatide
Ensure proper site rotation (not injecting the same spot repeatedly), use alcohol swabs consistently, and inject at room temperature (taking the vial out 15 to 20 minutes before injection can help)